Gene · 7398
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency. | Mol Cancer Ther | 2025 | 39886906 | PubTator, text mining | PubMed |
| USP1 in regulation of DNA repair pathways. | DNA Repair (Amst) | 2025 | 39848025 | PubTator, text mining | PubMed |
| The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy. | Future Med Chem | 2025 | 39819213 | PubTator, text mining | PubMed |
| USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14. | J Biol Chem | 2025 | 39814232 | PubTator, text mining | PubMed |
| High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression. | J Transl Med | 2025 | 39810156 | PubTator, text mining | PubMed |
| Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer. | Oncol Res | 2025 | 39735674 | PubTator, text mining | PubMed |
| Breaking new ground: Unraveling the USP1/ID3/E12/P21 axis in vascular calcification. | Transl Res | 2025 | 39326697 | PubTator, text mining | PubMed |
| Unravelling the molecular mechanistic pathway underlying the anticancer effects of kaempferol in colorectal cancer: a reverse pharmacology network approach. | Mol Divers | 2025 | 38795259 | PubTator, text mining | PubMed |
| ATAD5-BAZ1B interaction modulates PCNA ubiquitination during DNA repair. | Nat Commun | 2024 | 39627214 | PubTator, text mining | PubMed |
| RSK1 dependency in FLT3-ITD acute myeloid leukemia. | Blood Cancer J | 2024 | 39592591 | PubTator, text mining | PubMed |
| USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity. | Sci Adv | 2024 | 39536107 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC. | Cells | 2024 | 39513905 | PubTator, text mining | PubMed |
| Literature review: nuclear factor kappa B (NF-κB) regulation in human cancers mediated by ubiquitin-specific proteases (USPs). | Ann Transl Med | 2024 | 39507445 | PubTator, text mining | PubMed |
| Editorial: Protein post-translational modifications in the nervous system: from development to disease and ageing. | Front Mol Neurosci | 2024 | 39493286 | PubTator, text mining | PubMed |
| Mechanism of HOXA10 in nasopharyngeal carcinoma cell proliferation through the PTPRG-AS1/USP1 axis. | J Biochem Mol Toxicol | 2024 | 39445487 | PubTator, text mining | PubMed |
| Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness. | Int J Biol Sci | 2024 | 39430244 | PubTator, text mining | PubMed |
| The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors. | Cancer Res | 2024 | 39402989 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| USP1-mediated deubiquitination of KDM1A promotes the malignant progression of triple-negative breast cancer. | J Biochem Mol Toxicol | 2024 | 39318028 | PubTator, text mining | PubMed |
| CD98hc promotes drug resistance in extranodal natural killer/T cell lymphoma through tumor cell-derived small extracellular vesicles. | Sci Signal | 2024 | 39255338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7398/papers?page=6